Mondo Visione Worldwide Financial Markets Intelligence

FTSE Mondo Visione Exchanges Index:

News Centre

  • Dalian Commodity Exchange: Corn Starch Futures To Be Listed On 19th

    Date 16/12/2014

    On December 9, Dalian Commodity Exchange (DCE) issued the Notice on the Matters Related to the Listing and Trading of the Corn Futures Contracts, confirming that the corn starch futures will be listed and traded as of December 19, 2014 (Friday) and making clear the matters related to the listing and trading of the corn starch futures contracts.

  • Shanghai Stock Exchange Implements Aftermath Examination On Mergers, Acquisitions, Reorganizations In Non-license Category

    Date 16/12/2014

    With the registration system coming and the regulator streamlining administration and decentralizing authority, the intensification of regulation on information disclosure is being accelerated. Recently, the Shanghai Stock Exchange (SSE) released the “Notice of Carrying out Information Disclosure Work of Mergers, Acquisitions and Reorganizations in Non-license Category” (the “Notice” for short) in a bid to further carry out the regulatory idea of “Loosening Control and Cementing Regulation” and carry out relevant requirements of the China Securities Regulatory Commission (CSRC).

  • Strong Growth Possible Despite Global Growth, Monetary Policy Concerns - SIFMA Roundtable Of Economists Unveil End-Year 2014 Economic Outlook

    Date 16/12/2014

    SIFMA’s Economic Advisory Roundtable unveiled today its outlook for end-year 2014 and 2015, forecasting that the economy will grow at a 2.3 percent rate in full-year 2014 and will rise to 3.0 percent in 2015. Despite concerns of global growth and monetary policy uncertainty, the outlook for full year 2014 is slightly higher than the Roundtable’s previous prediction of 2.2 percent. 

  • Correction - Annual Changes To The NASDAQ Biotechnology Index

    Date 16/12/2014

    In a release issued under the same headline earlier today by The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) the ticker and exchange for Esperion Therapeutics, Inc. should read (Nasdaq:ESPR) (sted Nasdaq:EXPR).

  • SEC: Statement On Jury's Verdict In Trial Of BankAtlantic Bancorp, Inc. And Alan Levan - Andrew Ceresney, Director, Division Of Enforcement

    Date 16/12/2014

    We are pleased by today’s jury verdict finding that BankAtlantic Bancorp, Inc., now known as BBX Capital Corporation, and CEO Alan Levan, committed securities fraud in connection with BBX’s public disclosures and financial statements.  After a six-week trial, the jury found that Levan’s 2007 statements during BBX’s second quarter earnings conference call fraudulently misled investors regarding the financial health of the bank, that BBX’s 2007 annual report fraudulently understated the Bank’s loss for that year by approximately $53 million, and that Levan and BBX engaged in a course of business that operated as a fraud throughout 2007.  We will continue to hold CEOs and other senior executives of public companies accountable, including through trials, if they engage in financial fraud and other violations of the federal securities laws.